ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      59,943.52
      1.20%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Lexicon Pharmaceuticals Inc (LXRX)

      7. Lexicon Pharmaceuticals Inc (LXRX) News

      LXRX

      Lexicon Pharmaceuticals (LXRX)

      Lexicon Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:LXRX
      DateTimeSourceHeadlineSymbolCompany
      08/06/20094:22PMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/04/20096:30AMPR Newswire (US)Lexicon Initiates Phase 2 Clinical Trial of LX2931 in Patients With Rheumatoid ArthritisNASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/28/20098:31AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/28/20096:30AMPR Newswire (US)Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial ResultsNASDAQ:LXRX
      07/22/20096:30AMPR Newswire (US)Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2009 Financial Results on July 28, 2009NASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/21/20096:30AMPR Newswire (US)Lexicon's Drug Candidate LX1032 for Carcinoid Syndrome Receives Orphan Drug Designation From EMEANASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/07/20096:30AMPR Newswire (US)Lexicon Initiates Phase 2 Clinical Trial of LX1032 in Patients With Carcinoid SyndromeNASDAQ:LXRX
      06/12/20094:11PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/05/20092:14PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/05/200910:06AMEdgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/02/20098:55AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/02/20096:30AMPR Newswire (US)Lexicon Names Ajay Bansal Executive Vice President and Chief Financial OfficerNASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/27/20096:30AMPR Newswire (US)Lexicon to Present Clinical Data for LX1031 and LX1032 at Digestive Disease WeekNASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/22/20094:13PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/29/20095:29PMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/28/20098:29AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/28/20096:30AMPR Newswire (US)Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter ResultsNASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/27/20094:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/27/20094:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/27/20094:42PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/27/20094:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/27/20094:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/27/20094:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/27/20094:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/27/20094:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/27/20094:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/27/20094:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/21/20096:30AMPR Newswire (US)Lexicon to Provide Clinical Pipeline Update and Report First Quarter 2009 Financial Results on April 28, 2009NASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/13/20098:29AMEdgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/13/20096:30AMPR Newswire (US)Lexicon Pharmaceuticals 2008 Annual Report to Stockholders Available OnlineNASDAQ:LXRXLexicon Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:LXRX

      Your Recent History

      BIT
      P10RJ7
      Bnp Paribas Issuance
      BIT
      P1VE92
      NLBNPIT1VE92 20351221 5....
      Delayed Upgrade Clock